Showing results (1571-1580 of 1,855) with videos related to

Sort By:
Pageof 186
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Experimental Neurology|September 28, 2011
A mouse model of blast-induced mild traumatic brain injuryVardit Rubovitch, Meital Ten-Bosch, Ofer Zohar, et al.
Journal of Medicinal Chemistry|March 29, 2022
CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug ModulationKendall Carrasco, Camille Montersino, Carine Derviaux, et al.
Nature|March 21, 1996
Functional recovery in parkinsonian monkeys treated with GDNFD M Gash, Z Zhang, A Ovadia, et al.
Neurology|January 1, 1996
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseK L Marek, J P Seibyl, S S Zoghbi, et al.
The Journal of Trauma and Acute Care Surgery|August 19, 2016
Inducing metabolic suppression in severe hemorrhagic shock: Pilot study results from the Biochronicity ProjectGeorge E Black, Kyle K Sokol, Robert R Shawhan, et al.
Cells|July 6, 2023
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary MicrogliaElliot J Glotfelty, Luis B Tovar-Y-Romo, Shih-Chang Hsueh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2015
Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
The American Journal of Cardiology|November 29, 2005
Prevalence of mechanical dyssynchrony in patients with heart failure and preserved left ventricular function (a report from the Belgian Multicenter Registry on dyssynchrony)Johan De Sutter, Nico R Van de Veire, Luc Muyldermans, et al.
Radiation Oncology (London, England)|January 28, 2023
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cellsMeryem H Cetin, Thorsten Rieckmann, Konstantin Hoffer, et al.
Pageof 186